Destination China

Burnet Institute

26 July, 2018

Image: Dr Jack Richards, Burnet Group Head and NHMRC Postdoctoral Fellow

Burnet Institute Group Head Dr Jack Richards is looking forward to exploring new commercial opportunities as a participant in The Australia-China Young Scientists Exchange Program (YSEP) for 2018.

Dr Richards is one of 16 Australian researchers selected to visit China later this year with the support of YSEP, a joint initiative of the Australian Department of Industry, Innovation and Science, and the Chinese Ministry of Science and Technology.

Dr Richards’ itinerary includes the Infectious Disease Department at Jiangsu Hospital; the National Institute for Sexually Transmitted Infections in Nanjing; and Chinese Centre for Disease Control for Parasitic Diseases in Shanghai.

He’ll also visit Burnet’s Nanjing BioPoint Diagnostic laboratory in Jiangsu Province, which undertakes research and development of novel diagnostic tools in areas of unmet medical need.

Dr Richards is particularly interested in the development of a test for the enzyme, glucose-6-phosphate dehydrogenase (G6PD), because drugs for the treatment of Plasmodium vivax malaria are potentially lethal for people deficient in G6PD.

“I’ll spend a bit of time with the team at Nanjing BioPoint to see how they’re set up, their processes for manufacture and development to give me a better understanding of how they operate and what opportunities they’re looking at,” Dr Richards said.

“The G6PD test, that’s one of the things we’re thinking about, what’s the best way to push that to market, and getting a better idea of how Nanjing (BioPoint) works will give me a better insight into that.

“It’s going to be great, something really different for me.”

The YSEP aims to increase Australian and Chinese researchers’ understanding of the science and research practices and systems of the two countries; develop the researchers’ leadership skills as future science ambassadors; and provide a catalyst for long-tem, sustainable research collaboration.

“It will be nice to engage with a different group of people and to think across these different sectors and understand what the gaps are and what the opportunities will be,” Dr Richards said.

“I’m thrilled to do that and to bring that back to the group, because I think that will invigorate the whole group, and hopefully the Institute too.”

Contact Details

For more information in relation to this news article, please contact:

Associate Professor Jack Richards

Group Head, NHMRC Postdoctoral Fellow, Infectious Diseases Physician




[email protected]

Subscribe to News

Subscribe to receive our latest news: